<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIMS: Longer life expectancy in patients with prior <z:hpo ids='HP_0003002'>breast cancer</z:hpo> may increase their risk of developing other primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Whether the risk of developing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in this patient population is higher in comparison to those with no prior <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to compare the prevalence of colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> and any <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> survivors with those who have no history of prior <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and assess any difference with use of <z:chebi fb="0" ids="50751">antiestrogen</z:chebi> therapy </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We compared the prevalence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:mpath ids='MPATH_270'>adenomas</z:mpath> in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> survivors with that of a group of matched controls </plain></SENT>
<SENT sid="4" pm="."><plain>Eligible survivors were â‰¤85 years of age; had initially been diagnosed with stage 0, I, II, or III <z:hpo ids='HP_0003002'>breast cancer</z:hpo>; had completed <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatments with the exception of adjuvant <z:chebi fb="0" ids="50751">antiestrogen</z:chebi> therapy; and had no evidence of recurrence on follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>We used the screening colonoscopy database at our institution to identify age-, sex-, and race-matched controls with no history of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: We identified 302 study-eligible <z:hpo ids='HP_0003002'>breast cancer</z:hpo> survivors and 302 matched controls </plain></SENT>
<SENT sid="7" pm="."><plain>No <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> were found in either group </plain></SENT>
<SENT sid="8" pm="."><plain>Forty-one <z:hpo ids='HP_0003002'>breast cancer</z:hpo> survivors and 30 controls had tubular <z:mpath ids='MPATH_270'>adenomas</z:mpath>; four survivors and three controls had villous <z:mpath ids='MPATH_270'>adenoma</z:mpath>; and eight survivors and ten controls had advanced <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate regression analysis revealed that adjuvant <z:chebi fb="0" ids="50751">antiestrogen</z:chebi> therapy was not significantly associated with an increased risk of advanced <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The prevalence of colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> survivors and controls was similar </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0003002'>Breast cancer</z:hpo> survivors, including those receiving adjuvant <z:chebi fb="0" ids="50751">antiestrogen</z:chebi> therapies may follow the colorectal screening guidelines used for average-risk population </plain></SENT>
</text></document>